Y
Yawen Ding
Researcher at Nanjing University
Publications - 11
Citations - 309
Yawen Ding is an academic researcher from Nanjing University. The author has contributed to research in topics: Chemistry & Metastasis. The author has an hindex of 4, co-authored 7 publications receiving 149 citations.
Papers
More filters
Journal ArticleDOI
Tumor Oxygenation and Hypoxia Inducible Factor-1 Functional Inhibition via a Reactive Oxygen Species Responsive Nanoplatform for Enhancing Radiation Therapy and Abscopal Effects.
Lingtong Meng,Yali Cheng,Xiaoning Tong,Shaoju Gan,Yawen Ding,Yu Zhang,Chao Wang,Lei Xu,Yishen Zhu,Jinhui Wu,Yiqiao Hu,Ahu Yuan +11 more
TL;DR: A reactive oxygen species (ROS) responsive nanoplatform is reported to successfully add up tumor oxygenation and HIF-1 functional inhibition and achieve synergistically the optimal inhibition of tumor growth.
Journal ArticleDOI
Copper-Based Nanoscale Coordination Polymers Augmented Tumor Radioimmunotherapy for Immunogenic Cell Death Induction and T-Cell Infiltration.
TL;DR: In this paper, the authors constructed a Cu-based nanoscale coordination polymers (NCPs) with mixed-valence (Cu+ /Cu2+ ), which can simultaneously and independently induce the generation of Cu+ -triggered hydroxyl radicals and Cu2+ -driven GSH elimination, to synergize with radiation therapy for potent ICD induction.
Journal ArticleDOI
Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species
Lei Xu,Lei Xu,Zhicheng Zhang,Yawen Ding,Li Wang,Yali Cheng,Lingtong Meng,Jinhui Wu,Ahu Yuan,Yiqiao Hu,Yishen Zhu +10 more
TL;DR: Wang et al. as mentioned in this paper encapsulated one of the most effective HIF-1 inhibitors, acriflavine (ACF), and DOX in liposomes (DOX-ACF@Lipo) to construct a bifunctional liposome.
Journal ArticleDOI
Oxygen-rich chemotherapy via modified Abraxane to inhibit the growth and metastasis of triple-negative breast cancer.
Lingtong Meng,Shaoju Gan,Ya Zhou,Yali Cheng,Yawen Ding,Xiaoning Tong,Jinhui Wu,Yiqiao Hu,Ahu Yuan +8 more
TL;DR: Oxygen-rich chemotherapy was realized to efficiently sensitize paclitaxel, relieve acquired resistance and inhibit tumor metastasis, and results in about a 2-fold increase in inhibition efficiency of tumor growth in both primary and metastatic tumors compared with traditional Abx therapy.
Journal ArticleDOI
Novel copper-based and pH-sensitive nanomedicine for enhanced chemodynamic therapy
TL;DR: This work utilized albumin as a reducing agent to establish novel copper-based and pH-sensitive nanocarrier CuNPs with abundant Cu+, which can encapsulate histone deacetylase (HDAC) inhibitor vorinostat to form uniform and stable nanomedicine V-CuNPs for synergistic chromatin remodelling and chemodynamic therapy.